GSK CEO Emma Walmsley gave an upbeat assessment of the British drugmaker's new respiratory syncytial virus (RSV) vaccine on ...
The AstraZeneca office building in Brussels, Friday, Jan. 29, 2021. Amid a dispute over expected shortfalls, the European Union is looking at legal ways to guarantee the delivery of all the COVID-19 ...
The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them ...
The colder months bring opportunities to get sick, especially with holiday gatherings around the corner. Because of this, ...
The Food and Drug Adminstration (FDA) approved the first vaccine for the mosquito-born illness chikungunya on Thursday, a key step in fighting the dangerous virus. Chikungunya virus infects more ...
A first of its kind vaccine has been approved by the FDA to prevent infections with the chikungunya virus. The virus is most prevalent in semi-tropical and tropical areas, such as Central and ...
(CNN) — The US Food and Drug Administration said Thursday that it has approved the first vaccine to prevent disease caused by the chikungunya virus. Chikungunya, a mosquito-borne disease whose ...
Earlier this month, the U.S. Food and Drug Administration (FDA) approved Ixchiq, the world’s first licensed vaccine for the mosquito-borne chikungunya virus. The single-dose vaccine was developed by ...
WASHINGTON – The US health authorities on Thursday approved the world’s first vaccine for chikungunya, which the Food and Drug Administration (FDA) called “an emerging global health threat”.
The U.S Food and Drug Administration approved the first chikungunya vaccine- Ixchiq Ixchiq is administered as a single dose intra-muscularly for individuals over 18 years of age and older who are ...
